- Project Summary
- Study Duration
- Objectives
- Outcomes
- Team Members
- Publications
Project Summary
Dengue Fever, caused by Dengue Virus (DENV), and transmitted by Aedes aegypti or Aedes albopictus, is a major cause of morbidity and mortality. An estimated 3.9 billion people are at risk of infection globally and the risk profile is increasing with climate change. A large proportion of infections are asymptomatic or mild, and therefore clinical cases underestimate the true number of infections in a population.
Due to the limited availability of accurate diagnostics, many cases are also misdiagnosed, further underestimating the burden of disease. DENV belongs to the family Flaviviridae with four different serotypes (DENV-1, DENV-2, DENV-3, and DENV4). Several methods can be used to diagnose DENV infection, and their utility depends on when a patient presents after symptom onset. Serological methods, such as enzyme-linked immunosorbent assays (ELISA), may confirm the presence of a recent or past infection, with the detection of anti-dengue antibodies. IgM antibodies are detectable ~1 week after infection and remain detectable for about three months.
The presence of IgM is indicative of a recent DENV infection. IgG antibody levels take longer to develop and remain elevated for years. The presence of IgG is indicative of a past infection. At the local level, urbanization (especially unplanned), is associated with dengue transmission through multiple social and environmental factors including population density, human mobility, and water storage practices. A community’s susceptibility to dengue also depends on knowledge, attitude, and practice towards dengue, as well as the implementation of routine sustainable vector control activities in the community. At the global level, as a vector-borne disease, dengue transmission is highly influenced by climate. Consequently, disease risks may change and shift with climate change in tropical and subtropical areas, and vectors might adapt to new environments and climates.
In 2012, a total of 183 confirmed dengue cases were reported. More than forty percent (n=77) of these cases were from the Jhapa district alone, where an outbreak was reported from Mechinagar municipality and Dhulabari VDC. Of these 77 cases in Jhapa, 62% were male, and the majority of all infected people were adults. Similarly, in 2018 there was a cluster of cases reported from high elevation Kaski District of Gandaki Province.
Study Duration
From Nov 2022 – Oct 2023
Objectives
The overall objective is to understand the population-level burden of Dengue in Kathmandu and associated risk factors.
Outcomes
From this study, we obtained Population-based seroprevalence and seroincidence estimates for dengue fever infections with age, temporal and spatial trends. Additionally, we understood the risk factors associated.
Team Members
Principal Investigator(s): Dr. Dipesh Tamrakar
Co-Investigator(s): Prof. Dr. Rajeev Shrestha, Ms. Kristen Aiemjoy, Mr. Sabin Bikram Shahi, Mr. Shiva Ram Naga, Ms. Aastha Shrestha, Mr. Nishan Katuwal
Project Coordinator(s): Ms. Aastha Shrestha
Research Assistant(s): Ms. Urusha Ranjitkar, Ms. Sudichhya Tamrakar
Supported by: National Institute of Health (NIH), United States
Collaborating Partners: University of California-Davis (UC Davis), United States
Publications
Not Yet Published







